REDUCTION OF HEALTH COSTS

MEDICAL MARKETING SUPERHEROES

BLOCKCHAIN TECHNOLOGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

The Virtual World of Digital Clinical Trials

Academic Ventures and Professional Service Companies

MICRONEEDLE ARRAY PATCHES

Systematic Framework for Implementation of RTD-based Control System into Continuous Pharmaceutical Manufacturing Pilot-plant

CUSTOMER CENTRICITY ON SOCIAL MEDIA

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

Get instant access to latest e-book

LATEST NEWSRead more...

17

May 2019

RegeneRx Partner Receives Patent for New Ophthalmic Formulation of Thymosin Beta 4

RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration reported today that its US joint venture partner and Pan Asian licensee GtreeBNT has been granted a new US patent for a method of preventing or treating dry eye syndrome

17

May 2019

Intec Pharma Announces Research Collaboration Agreement With Merck

Intec Pharma Ltd today announces it has entered into an agreement with Merck known as MSD outside the United States and Canada to explore using the Accordion Pill AP platform for an undisclosed development program

16

May 2019

Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

Cumberland Pharmaceuticals Inc a specialty pharmaceutical company today announced it has entered into an exclusive agreement with Chinas Winhealth Pharma Group for the licensing rights of Acetadote acetylcysteine Injection used to prevent or reduce liver damage resulting from acetaminophen overdose...

16

May 2019

Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases

Vertex Pharmaceuticals Incorporated and Kymera Therapeutics today announced that the two companies have entered into a fouryear strategic research and development collaboration to advance small molecule protein degraders against multiple targets

15

May 2019

Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus

Hoth Therapeutics Inc a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitisalso known as eczemaas well as dermatological and chronic wound disorders today announced that the company has signed a term sheet with Zyl Thera...

press releasesRead more...

17

May 2019

Strong line-up: Chemspec Europe 2019 gathers impressive array of industry experts under one roof

Preparations for the International Exhibition for Fine and Speciality Chemicalsare well under way From June the thedition of Chemspec Europe provides a powerful and wellknown industry platform to explore bespoke solutions new approaches and innovative substances as well as to discuss the latest m...

17

May 2019

Lonza Chooses Synpromics’ Novel Inducible Promoter Platform to Manufacture Biopharmaceuticals

Synpromics Ltd the leader in gene control and Lonza Pharma Biotech announce a partnership for the commercialization of a number of inducible promoters to improve the manufacturing of biopharmaceuticals The commercial agreement with Lonza follows the award of an Innovate UK grant to Synpromics annou...

17

May 2019

Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects

Altasciences a midsize CRO specializing in a flexible innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept announced today that they have entered into an agreement to support WuXi AppTecs Investigational New Drug WIND platform

17

May 2019

Scintomics and 1717 Life Science Ventures form joint venture PENTIXAPHARM for the development of CXCR4-targeted theranostics

As Scintomics GmbH and Life Science Ventures GmbH announced today the companies have signed an agreement to cooperate in the development of the Theranostik couple PentixaFor PentixaTher

16

May 2019

Visit Asia’s Leading Exhibition for Pharma R&D and Manufacturing Technologies

INTERPHEX Week Japan is Asias leading pharma and cosmetics RD and manufacturing technology show with exhibitors and visitors The show consists of exhibitions for pharmaceutical technologies

EventsRead more...

20 - 21

May 2019

6th Due Diligence Summit for Life Sciences

Sonesta Philadelphia Downtown Rittenhouse Square

20 - 23

May 2019

TIDES: Oligonucleotide and Peptide Therapeutics

KNect365
Manchester Grand Hyatt

20 - 21

May 2019

11th World Conference on Biosimilars and Biologics

Meetings International Pte Ltd
Miami

21 - 23

May 2019

Neuroimmunology Drug Development Summary Summit

Hanson Wade
Hilton Paris La Defense

AirBridgeCargo - Air frieght solutions for your Pharma

ACG’s Packdoctors - Get your common packaging problems treated

$Matcon Efficently handling tablets and powders in IBC\'s$

KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

Articles

Industry 4.0: a closed micronization system

FPS is an Italian company specialized in the production of containment and micronization systems for Pharmaceutical Biotech and Fine Chemical companies

Research Insights

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in

Case Studies

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime

Techno Trends

PhaseBio to Announce PB2452, a Novel Reversal Agent for Antiplatelet Drug Ticagrelor

PhaseBio Pharmaceuticals is planning to announce PB a novel reversal agent for the Antiplatelet drug Ticagrelor PB is a novel recombinant human monoclonal antibody antigenbinding fragment or Fab fragment designed to reverse the Antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations

White Papers

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Seventy years ago average life expectancy globally was today it is Seventy years ago million people worldwide were infected with smallpox today non...

RESEARCH DEVELOPMENT

Academic Ventures and Professional Service Companies

Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive...

CLINICAL TRIALS

Speed, Quality and Cost

In recent years the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market being under increasin...

MANUFACTURING

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

The key to successfully developing and shepherding a drug to the approval stage and beyond lies in careful planning right from the start of developmen...

Information Technology

CUSTOMER CENTRICITY ON SOCIAL MEDIA

Imagine checking into a hotel late in the night but not being able to get the room you had so carefully chosen because the call centre didnt align wit...

EXPERT Talk

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach

What is the current consensus on the ICH E R Addendum within SMEs The complexity and size of clinical trials has intensified over recent years alo...

REDUCTION OF HEALTH COSTS

MEDICAL MARKETING SUPERHEROES

BLOCKCHAIN TECHNOLOGY

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

The Virtual World of Digital Clinical Trials

Academic Ventures and Professional Service Companies

MICRONEEDLE ARRAY PATCHES

Systematic Framework for Implementation of RTD-based Control System into Continuous Pharmaceutical Manufacturing Pilot-plant

CUSTOMER CENTRICITY ON SOCIAL MEDIA

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

Get instant access to latest e-book

LATEST NEWSRead more...

17

RegeneRx Partner Receives Patent for New Ophthalmic Formulation of Thymosin Beta 4

17

Intec Pharma Announces Research Collaboration Agreement With Merck

16

Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

16

Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases

15

Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus

press releasesRead more...

17

Strong line-up: Chemspec Europe 2019 gathers impressive array of industry experts under one roof

17

Lonza Chooses Synpromics’ Novel Inducible Promoter Platform to Manufacture Biopharmaceuticals

17

Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects

17

Scintomics and 1717 Life Science Ventures form joint venture PENTIXAPHARM for the development of CXCR4-targeted theranostics

16

Visit Asia’s Leading Exhibition for Pharma R&D and Manufacturing Technologies

EventsRead more...

20 - 21

6th Due Diligence Summit for Life Sciences

20 - 23

TIDES: Oligonucleotide and Peptide Therapeutics

20 - 21

11th World Conference on Biosimilars and Biologics

21 - 23

Neuroimmunology Drug Development Summary Summit

Advertisements

TOP ARTICLES

1

Nanomedicines management for advance therapy of NeuroAIDS: State of art

2

Mock-up in The Design Stage - FPS’s particular attention

3

MicroRNA (miRNA) in Nanostructure Lipid Carriers based Tumor Gene Therapy

4

Identification of MicroRNAs and Their Targets in Cancer

5

Are you Ready for EU FMD?

KNOWLEDGE BANK

Merck

Industry 4.0: a closed micronization system

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

PhaseBio to Announce PB2452, a Novel Reversal Agent for Antiplatelet Drug Ticagrelor

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Advisory Board

EDITORIAL SECTION

ETHICAL BUSINESS STIMULATES BEST VALUE IN HEALTH ECONOMY

Academic Ventures and Professional Service Companies

Speed, Quality and Cost

CLINICAL MANUFACTURING ON TIME AND WITHIN BUDGET

CUSTOMER CENTRICITY ON SOCIAL MEDIA

How SMEs Can Achieve Regulatory Compliance through a Risk-Based Approach